We equip customers with key advantages through nanolithography solutions
We equip customers with key advantages through nanolithography solutions
Explore Nanolithography
Obducat gives presentation on ”Nanoimprint Lithography (NIL)-Based Patterning of Chemically Strengthened Glass Sheets”
The presentation will be held at the EIPBN conference - 65th International Conference on Electron, Ion and Photon Beam Technology and Nanofabrication, which will take place between May 31 and June 3, 2022, in New Orleans, Louisiana.
Sorrento Therapeutics highlights the Sofusa® Drug Delivery System in Covid-19 Vaccine Development program
The Sofusa® Drug Delivery System, for which Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles, was highlighted in Sorrento Therapeutics proprietary mRNA vaccine development program for COVID-19.
Obducat customer Sorrento Therapeutics reports positive results
Sorrento Therapeutics, a biopharmaceutical company, reports positive initial result in dosing with the Sofusa® Lymphatic Drug Delivery Device. Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles used in the Sofusa® Drug Delivery System.
Obducat is an innovative developer and world-leading supplier of micro-and nano lithography solutions. We supply the technology, products and processes used for advanced micro- and nanopatterning of surfaces.
Press Release
Obducat receives order for production service to a value of approximately SEK 1.2 million
OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on Nanoimprint Lithography (NIL), has received an order from a customer concerning production service. The order value amounts to approximately SEK 1.2 million. The customer is a European player in the field of functional films and the order refers to the…
Read more